TAK-505
/ Takeda
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 28, 2026
A Study of TAK-505 in Adults With Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=151 | Not yet recruiting | Sponsor: Takeda
First-in-human • Monotherapy • New P1/2 trial • Colorectal Cancer • Gastric Cancer • Head and Neck Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma of Head and Neck • ALK • BRAF • MSI • RET • ROS1
1 to 1
Of
1
Go to page
1